UK markets closed

Guardant Health, Inc. (GH)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
119.04-0.40 (-0.33%)
At close: 4:00PM EDT
119.04 0.00 (0.00%)
After hours: 04:43PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 512.04B
Enterprise value 311.55B
Trailing P/E N/A
Forward P/E 1-38.28
PEG ratio (5-yr expected) 1-2.71
Price/sales (ttm)40.41
Price/book (mrq)14.21
Enterprise value/revenue 338.76
Enterprise value/EBITDA 7-38.44

Trading information

Stock price history

Beta (5Y monthly) 0.50
52-week change 342.65%
S&P500 52-week change 334.82%
52-week high 3181.07
52-week low 377.69
50-day moving average 3120.89
200-day moving average 3140.37

Share statistics

Avg vol (3-month) 3982.1k
Avg vol (10-day) 3752.64k
Shares outstanding 5101.12M
Implied shares outstanding 6N/A
Float 96.38M
% held by insiders 14.39%
% held by institutions 187.69%
Shares short (29 Jun 2021) 43.93M
Short ratio (29 Jun 2021) 43.51
Short % of float (29 Jun 2021) 44.07%
Short % of shares outstanding (29 Jun 2021) 43.89%
Shares short (prior month 27 May 2021) 43.98M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)30 Mar 2021


Profit margin -112.70%
Operating margin (ttm)-106.82%

Management effectiveness

Return on assets (ttm)-12.07%
Return on equity (ttm)-37.05%

Income statement

Revenue (ttm)297.88M
Revenue per share (ttm)3.00
Quarterly revenue growth (yoy)16.50%
Gross profit (ttm)194.19M
EBITDA -300.42M
Net income avi to common (ttm)-335.71M
Diluted EPS (ttm)-3.39
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.94B
Total cash per share (mrq)19.19
Total debt (mrq)1.35B
Total debt/equity (mrq)148.96
Current ratio (mrq)21.29
Book value per share (mrq)8.38

Cash flow statement

Operating cash flow (ttm)-106.94M
Levered free cash flow (ttm)-14.31M